Literature DB >> 10232869

The sense of coherence index and the irritable bowel syndrome. A cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls.

A D Sperber1, S Carmel, Y Atzmon, I Weisberg, Y Shalit, L Neumann, A Fich, D Buskila.   

Abstract

BACKGROUND: Sense of Coherence (SOC) is a global orientation that affects coping with stressors. A strong SOC is associated with better health outcomes. The purpose of this study was to evaluate SOC among patients with irritable bowel syndrome (IBS) and matched controls.
METHODS: Seventy-nine IBS patients and 72 matched controls completed questionnaires and were tested for fibromyalgia (FS). The controls were subdivided into healthy controls (n = 49) or IBS non-patients (n = 23), and the patients into IBS only (n = 54) or IBS and FS (n = 25).
RESULTS: The mean SOC score was higher for the controls than for the IBS patients (65.7+/-1.2 and 59.6+/-1.1, respectively; P = 0.003). There was no significant difference between the healthy controls and the IBS non-patients. The controls had a higher SOC than patients with IBS only and patients with IBS and FS (P = 0.0004).
CONCLUSIONS: An association was found between IBS and SOC. No causality can be inferred from this study. Individuals with low SOC may be more likely to express symptoms in terms of psychologic distress and increased health care utilization because of poor coping skills. Conversely, the presence of IBS may affect SOC negatively. Further longitudinal studies could clarify the potential of SOC as a predictor variable (for example, for treatment results) or an outcome variable.

Entities:  

Mesh:

Year:  1999        PMID: 10232869     DOI: 10.1080/00365529950173654

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective.

Authors:  Ami D Sperber; Douglas A Drossman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

2.  The Effects of Pythagorean Self-Awareness Intervention on Irritable Bowel Syndrome Patients: A Non-randomized Controlled Trial.

Authors:  Kleopatra Gorgili; Artemios Artemiadis; Flora Bacopoulou; Pantelis Karatzas; Xanthi Tigani; Dimitrios Vlachakis; Ioulia Kokka; Liza Varvogli; George P Chrousos; Christina Darviri
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

4.  Constructive thinking, rational intelligence and irritable bowel syndrome.

Authors:  Enrique Rey; Marta Moreno Ortega; Monica-Olga Garcia Alonso; Manuel Diaz-Rubio
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

5.  Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center.

Authors:  Prashant Singh; Abhishek Agnihotri; Manish K Pathak; Asef Shirazi; Rajeew P Tiwari; V Sreenivas; Rajesh Sagar; Govind K Makharia
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

6.  Body awareness therapy: a new strategy for relief of symptoms in irritable bowel syndrome patients.

Authors:  E M Eriksson; I E Möller; R H Söderberg; H T Eriksson; G K Kurlberg
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

7.  Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents.

Authors:  Peter Przekop; Mark G Haviland; Yan Zhao; Keiji Oda; Kelly R Morton; Gary E Fraser
Journal:  J Am Osteopath Assoc       Date:  2012-11

8.  Validation of New Symptom-Based Fibromyalgia Criteria for Irritable Bowel Syndrome Co-morbidity Studies.

Authors:  Ami D Sperber; Smadar Akiva; Moshe Leshno; Zamir Halpern; Dan Buskila
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

9.  Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care.

Authors:  Åshild Faresjö; Ewa Grodzinsky; Claes Hallert; Toomas Timpka
Journal:  BMC Public Health       Date:  2013-09-11       Impact factor: 3.295

Review 10.  Fibromyalgia: the gastrointestinal link.

Authors:  Daniel J Wallace; David S Hallegua
Journal:  Curr Pain Headache Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.